Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$396M |
| 2 |
JPMorgan Chase
JPM
|
+$167M |
| 3 |
Extra Space Storage
EXR
|
+$148M |
| 4 |
GE HealthCare
GEHC
|
+$120M |
| 5 |
Patterson-UTI
PTEN
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PDCE
PDC Energy, Inc.
PDCE
|
+$313M |
| 2 |
Super Micro Computer
SMCI
|
+$310M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$176M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$160M |
| 5 |
Walmart Inc
WMT
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.29% |
| 2 | Financials | 16.14% |
| 3 | Industrials | 13.23% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Flexible Solutions
FSI
$64.5M
| $162K | ﹤0.01% |
59,474
-3,851
| -6% | -$10.5K |
|
3252
Standard BioTools
LAB
$311M
| $158K | ﹤0.01% |
54,398
| – | – |
|
3253
ThredUp
TDUP
$760M
| $156K | ﹤0.01% |
38,865
+16
| +0% | +$54 |
|
3254
Viridian Therapeutics
VRDN
$2.15B
| $154K | ﹤0.01% |
10,070
| – | – |
|
3255
Immunic
IMUX
$182M
| $154K | ﹤0.01% |
10,450
+6,627
| +173% | +$127K |
|
3256
Barnwell Industries
BRN
$13.7M
| $152K | ﹤0.01% |
57,856
+8
| +0% | +$21 |
|
|
PMD
3257
DELISTED
Psychemedics Corporation
PMD
| $152K | ﹤0.01% |
38,184
-17,971
| -32% | -$80.2K |
|
3258
Black Diamond Therapeutics
BDTX
$101M
| $150K | ﹤0.01% |
52,258
+35,171
| +206% | +$130K |
|
3259
Oric Pharmaceuticals
ORIC
$1.23B
| $149K | ﹤0.01% |
24,692
+16
| +0.1% | +$131 |
|
3260
Cytosorbents Corp
CTSO
$23.3M
| $149K | ﹤0.01% |
79,458
-6,558
| -8% | -$18.8K |
|
3261
Harte-Hanks
HHS
$16.3M
| $149K | ﹤0.01% |
22,923
-17,448
| -43% | -$102K |
|
|
UDMY
3262
DELISTED
Udemy
UDMY
| $149K | ﹤0.01% |
15,694
| – | – |
|
|
ZYXI
3263
DELISTED
Zynex
ZYXI
| $147K | ﹤0.01% |
18,421
-493
| -3% | -$4.13K |
|
|
KLR
3264
DELISTED
Kaleyra, Inc.
KLR
| $146K | ﹤0.01% |
+20,207
| New | +$139K |
|
3265
Tyra Biosciences
TYRA
$1.84B
| $146K | ﹤0.01% |
10,609
+8
| +0.1% | +$119 |
|
3266
Paysign
PAYS
$510M
| $146K | ﹤0.01% |
74,867
-59,982
| -44% | -$124K |
|
|
LEV
3267
DELISTED
The Lion Electric Company
LEV
| $144K | ﹤0.01% |
+75,230
| New | +$163K |
|
3268
Fathom Holdings
FTHM
$28.5M
| $144K | ﹤0.01% |
35,208
+22,296
| +173% | +$145K |
|
|
FLNT
3269
Fluent
FLNT
$103M
| $143K | ﹤0.01% |
53,841
-9,243
| -15% | -$34.6K |
|
3270
US Global Investors
GROW
$37.2M
| $143K | ﹤0.01% |
50,202
| – | – |
|
3271
MiMedx Group
MDXG
$649M
| $143K | ﹤0.01% |
19,601
| – | – |
|
|
FNA
3272
DELISTED
Paragon 28, Inc.
FNA
| $143K | ﹤0.01% |
+11,373
| New | +$172K |
|
|
MRSN
3273
DELISTED
Mersana Therapeutics
MRSN
| $143K | ﹤0.01% |
4,489
-3,095
| -41% | -$147K |
|
3274
908 Devices
MASS
$288M
| $143K | ﹤0.01% |
21,397
+8,290
| +63% | +$57.4K |
|
3275
Solid Biosciences
SLDB
$785M
| $139K | ﹤0.01% |
55,090
-7,074
| -11% | -$27.4K |
|
Similar funds
Dimensional Fund Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Dimensional Fund Advisors held 3,560 positions worth $305B, down 2.8% from $314B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.9%. Dimensional Fund Advisors opened 80 new positions and exited 93, leaving the 3,560-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2023 buy was Kenvue: 17,128,393 shares worth $344M.
- Dimensional Fund Advisors added most to JPMorgan Chase in Q3 2023, an estimated $167M increase.
- Dimensional Fund Advisors's biggest Q3 2023 reduction was Super Micro Computer, cutting an estimated $310M.
- Dimensional Fund Advisors fully exited PDC Energy, Inc. in Q3 2023, selling an estimated $313M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $305B portfolio in Q3 2023.
- Dimensional Fund Advisors opened 80 new positions and closed 93 in Q3 2023.
- Dimensional Fund Advisors's portfolio value fell 2.8% quarter-over-quarter to $305B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.